• 13 May 2019

SPA Healthcare - Morning Comment

Novacyt, 90.0 | Polarean Imaging, 26.5

    • Vadim Alexandre

    • 4 pages

Medical Equipment & Services image


 
Medical Equipment & Services image


Novacyt (NCYT.l) Launch of new molecular testing instrument | Polarean Imaging: Clinical trial update


Sign up to access

Get access to our full offering from over 30 providers

Get access to our full offering from over 30 providers


Get Started
Already a member? Log in here

More Content

More Content

SP Angel Healthcare Conditions

Companies: Novacyt Feedback

Morning Report: Polarean Imaging reports Phase III success for its lung scanning technology

Companies: Polarean Imaging

SP Angel Healthcare Conditions

Companies: Novacyt

Polarean Imaging achieves positive phase III results in two clinical trials

Companies: Polarean Imaging

Morning Report: Novacyt reports 'unprecedented interest' in its coronavirus diagnostic

Companies: Novacyt

Copyright © 2020 Research Tree | All Rights Reserved. | Terms of Service and Privacy Policy and Statement on Cookies

Research Tree will never share your details with third parties for marketing purposes. Research Tree distributes research documents that have been produced and approved by Financial Conduct Authority (FCA) Authorised & Regulated firms as well as relevant content from non-authorised sources, who are not regulated but the information is in the public domain. For the avoidance of doubt Research Tree is not giving advice, nor has Research Tree validated any of the information.

Research Tree is an Appointed Representative of Sturgeon Ventures which is Authorised and Regulated by the Financial Conduct Authority.

Tools licensed and contents implemented and optimized by Digital Look Ltd.

DigitalLook |Web Financial Group

©1999-2013 – Digital Look Ltd. A Web Financial Group Company All rights reserved. Legal notice.

Top